Renuka Iyer, MD, named new Chief Medical Officer for National Comprehensive Cancer Network (NCCN)
Acclaimed oncologist from Roswell Park Comprehensive Cancer Center to help lead nonprofit responsible for gold standard guidelines that define and advance cancer care worldwide
2025-12-04
(Press-News.org) PLYMOUTH MEETING, PA [December 4, 2025] — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers that publishes free evidence-based, expert consensus-driven guidelines for cancer prevention and care—today announced the hiring of Renuka Iyer, MD, as the new Chief Medical Officer (CMO) for the organization.
Dr. Iyer has a long history of leadership and innovation in oncology. She currently serves as a Professor of Oncology for Roswell Park Comprehensive Cancer Center—one of NCCN’s Member Institutions—as well as Section Chief of Gastrointestinal Oncology and Vice Chair of Faculty Affairs in Roswell Park’s Department of Medicine, and Medical Director for Medical Oncology across the Roswell Park Care Network. She also serves as a Professor of Medicine at Jacobs School of Medicine at the University of Buffalo.
Fellowship-trained in medical oncology at Roswell Park, Dr. Iyer attended Grant Medical College at the University of Mumbai, followed by residency at Cornell University School of Medicine. She is board certified in internal medicine and oncology; a member of numerous professional societies; the recipient of several awards from organizations that include the North American Neuroendocrine Tumor Society, The Cholangiocarcinoma Foundation, and American Cancer Society; and has published hundreds of peer-reviewed articles, abstracts, and book chapters. Her research focuses on novel therapies for rare cancers, immunotherapy, biomarkers, and quality of life.
“Renuka is the perfect person to take on such an important role impacting treatment and outcomes for people with cancer around the world,” said Crystal S. Denlinger, MD, Chief Executive Officer, NCCN. “Over the years, she has shown a remarkable commitment to advancing research and improving care so all people can live better lives. She has devoted her career to driving innovations and putting them into practice. Renuka has been a major contributor to NCCN’s mission for years; we look forward to seeing what she will do to enhance access to high-quality, high-value, patient-centered cancer care in the future.”
Dr. Iyer has served as a member of the NCCN Guidelines Steering Committee since 2023. As a Steering Committee member, she helps provide strategic oversight to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) program, including assigning subject matter experts to panels and advising NCCN regarding future direction. Prior to that, she served as a panelist for the NCCN Guidelines® Panels for Occult Primary Cancer and Hepatobiliary Cancer, in addition to serving on other professional organization guidelines panels.
In her new role as NCCN CMO, Dr. Iyer will play an even larger role with the NCCN Guidelines program, which consists of 90 guidelines for treating nearly every type of cancer, along with prevention, screening, and supportive care. Each of the NCCN Guidelines is updated at least once per year and often far more frequently than that. They are available in multiple formats, including via the new, interactive NCCN Guidelines Navigator™.
Dr. Iyer’s work will include clinical leadership for the NCCN Guidelines program and oversight for additional point-of-care resources based on the NCCN Guidelines, including the Library of NCCN Compendia. She will also oversee NCCN’s Continuing Education (CE) department, JNCCN—Journal of the National Comprehensive Cancer Network, and participate in Global and Policy efforts.
“I am honored to be chosen for this prestigious position and excited to be at NCCN during a time when there are so many updates and opportunities to innovate how we deliver information to help our patients,” said Dr. Iyer. “After 21 years in academic oncology, I welcome the opportunity to advance high-quality cancer care and to help build bridges to further the NCCN mission.”
Dr. Iyer’s first day as CMO will be February 26, 2026.
# # #
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is marking 30 years as a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to defining and advancing quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus-driven recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-12-04
Los Angeles, CA – December 4, 2025 – Dr. Vadim Jucaud’s lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates age-dependent immune responses, offering a more accurate testing bed for evaluating cancer vaccine performance in older adults, the population most affected by cancer and often overlooked in traditional preclinical testing.
Immunosenescence, the natural decline of the immune system with age, significantly reduces the effectiveness of cancer vaccines. Yet, despite its clinical importance, age-related immune decline is seldom incorporated into vaccine development pipelines. Current 2D ...
2025-12-04
Europe is gobbling up almost 50 square metres of land and topsoil per second. And Norway tops the list of European countries with the most land lost to construction per person, according to a study initiated by the Arena for Journalism in Europe and the Norwegian Broadcasting Corporation, NRK. At the same time, we have never had access to more data and knowledge about nature and the ecosystems we are building on.
"We are acquiring more and more ecological data as a basis for land-use planning. Then you would think that the decisions we make ...
2025-12-04
In newly published research, Binghamton University doctoral student Elana Israel, MS ’22, explores which depressive symptoms largely affect children’s neural responses to feedback.
Depression in parents can affect a child’s reward processing, or how their brains react to positive and negative feedback. Israel and Psychology Professor Brandon Gibb, director of the Mood Disorders Institute, explored whether a specific symptom of depression in parents known as anhedonia, a loss of interest or pleasure in things, may be specifically responsible for this link. The study will be included in ...
2025-12-04
Ambiguous speech production is a common challenge for learners of a second language (L2), but identifying whether the problem lies in pronunciation or deeper linguistic processing is not always straightforward. A new study conducted by Professor Sylvain Detey from Waseda University, with Dr. Verdiana De Fino from IRIT, UT3, University of Toulouse & Archean Labs, France, and Dr. Lionel Fontan, Head of Archean Labs, France, sheds light on this distinction. Their study was published on October 30, 2025, in the journal Language Testing in Asia.
The researchers sought to determine whether ambiguous speech errors made by Japanese learners of French could be better categorized through a combined ...
2025-12-04
Advances in materials science have led to the development of “smart materials,” whose properties do not remain static but change in response to external stimuli. One such material is poly(N-isopropylacrylamide), or PNIPAM, a polymer gel that alters its solubility with temperature. The polymer contains hydrophilic amide groups and hydrophobic isopropyl groups. At low temperatures, the amide groups form strong hydrogen bonds with water, keeping the material well-swollen and soluble. However, as the temperature increases, these hydrogen bonds weaken while ...
2025-12-04
Extracellular vesicles (EVs) have rapidly emerged as one of the most promising frontiers in modern biology. These nano-sized messengers mediate communication between cells, tissues, and organs, influencing processes from immune signaling to cancer progression. Their growing diagnostic, prognostic, and therapeutic relevance has accelerated research worldwide. Yet one major limitation persists: the absence of efficient, scalable, and equipment-independent EV isolation methods. Existing techniques, including ultracentrifugation and size-exclusion chromatography (SEC), remain labor-intensive, instrumentation-heavy, and unsuitable for processing large-volume biofluids.
To ...
2025-12-04
Nicotine addiction remains one of the most persistent public health challenges worldwide, driven by changes in the brain that reinforce repeated use and make quitting extremely difficult. For decades, scientists have focused primarily on neurons to explain how these changes occur. But growing evidence suggests that other brain cells may play a far more active role in shaping addictive behavior than previously thought.
Building on this shift in understanding, a team of researchers led by Professor Eun Sang Choe from the Department of Biological Sciences, Pusan National ...
2025-12-04
A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in breast cancer treatment, making immunotherapy effective against the most common tumor type, estrogen receptor-positive or luminal breast cancer. This subtype accounts for 70% of breast cancer cases, and despite effective treatments, it causes the highest mortality in total cases. Additionally, immunotherapy is not effective or approved because it shows no immune system response in these tumors, ...
2025-12-04
CHICAGO – Long-term exposure to common air pollutants is associated with more advanced coronary artery disease—with notable differences between women and men—according to a large-scale study of more than 11,000 adults being presented today at the annual meeting of the Radiological Society of North America (RSNA).
The findings show that even levels of pollution below or near regulatory standards and typical urban exposures are associated with early signs of heart disease—often before symptoms appear—and underscore the importance of improving air quality to reduce cardiovascular ...
2025-12-04
Kyoto, Japan -- "Why are we here?" is humanity's most fundamental and persistent question. Tracing the origins of the elements is a direct attempt to answer this at its deepest level. We know many elements are created inside stars and supernovae, which then cast them out into the universe, yet the origins of some key elements has remained a mystery.
Chlorine and potassium, both odd-Z elements -- possessing an odd number of protons -- are essential to life and planet formation. According to current theoretical models, stars ...
LAST 30 PRESS RELEASES:
[Press-News.org] Renuka Iyer, MD, named new Chief Medical Officer for National Comprehensive Cancer Network (NCCN)
Acclaimed oncologist from Roswell Park Comprehensive Cancer Center to help lead nonprofit responsible for gold standard guidelines that define and advance cancer care worldwide
